Sumitomo Heavy Of Japan To Promote Proton-Therapy Device Abroad
This article was originally published in PharmAsia News
Executive Summary
Japan's Sumitomo Heavy Industries is relying on a relatively small and low-cost proton-therapy system to draw foreign sales as a cancer treatment